Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
LiVeritas Biosciences provides mass spectrometry-based analytical services and digital twin solutions to accelerate drug quality, safety, and efficacy testing. Their platform enables biopharma companies to streamline CMC analytics from preclinical through clinical development with rapid turnaround times (<3 weeks standard, <1 week accelerated), supporting modalities such as antibodies, ADCs, gene/cell therapies, small molecules, and oligonucleotides. They do not have their own therapeutic programs or clinical results.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on LiVeritas Biosciences.